Arnstein Paul, Broglio Kathleen, Wuhrman Elsa, Kean Mary Beth
Massachusetts General Hospital, Boston, MA 02114, USA.
Pain Manag Nurs. 2011 Dec;12(4):225-9. doi: 10.1016/j.pmn.2010.10.033. Epub 2011 Mar 3.
The American Society for Pain Management Nursing (ASPMN) holds the position that a placebo should not be used by any method to assess and/or manage an individual's pain regardless of their age or diagnosis. The only justifiable use of placebos is for participants enrolled in a blinded clinical trial. These clinical trials must be Institutional Review Board (or equivalent) approved with participants clearly informed that they may receive a placebo before they consent to participate and actually have the sham treatment administered.
美国疼痛管理护理协会（ASPMN）的立场是，无论年龄或诊断如何，任何方法都不应使用安慰剂来评估和/或管理个人的疼痛。安慰剂唯一合理的用途是用于参加双盲临床试验的参与者。这些临床试验必须得到机构审查委员会（或同等机构）的批准，并且要明确告知参与者，在他们同意参与并实际接受假治疗之前，他们可能会接受安慰剂。
